ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,843 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryLausannefondation Innovative Medicines for Tuberculosis (iM4TB)
fondation Innovative Medicines for Tuberculosis (iM4TB) Logo
Verified· 2 sources

fondation Innovative Medicines for Tuberculosis (iM4TB)

Summary

About the company

The core activity of iM4TB is the development of innovative medicines to combat tuberculosis. The company researches and develops new treatment methods and agents to eliminate tuberculosis.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered4
Development of New Tuberculosis Medicines
Development of better and faster-acting medicines against tuberculosis, including preclinical and clinical development, to enable affordable TB treatment.
Development of Tuberculosis Treatment Regimens (ERA4TB)
Accelerating the development of new tuberculosis treatment regimens in a public-private consortium, with a parallel pipeline and preparation for a Phase II assessment.
Development of the Active Substance PBTZ169 (Macozinone)
Preclinical and clinical development of the TB active substance candidate PBTZ169, including Phase Ia and Phase Ib studies as well as preparation for further development steps.
Funding and Bridging Support for TB Research
Financial support for preclinical and clinical development phases to move promising tuberculosis molecules through the early development stage.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Knowledge

No knowledge articles yet

Once fondation Innovative Medicines for Tuberculosis (iM4TB) has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

fondation Innovative Medicines for Tuberculosis (iM4TB) in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank fondation Innovative Medicines for Tuberculosis (iM4TB) by reviews, experience and specialisations.

Is this your company?

Claim the company profile of fondation Innovative Medicines for Tuberculosis (iM4TB) to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

EPFL
1015 Lausanne
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Foundation
UID
CHE-270.892.523
Founded
2014 · 12 years
Last commercial register change
February 17, 2026
Employees
11 to 20

Similar companies

AB
AB2 Bio SA
Lausanne
AS
Axalbion SA
Lausanne
LL
LRK Laboratoire homéopathique de recherches Kurtoglu SA
Cugy Vd
OS
Oligopharm SA
Cugy Vd
IB
Incyte Biosciences International Sàrl
Morges
AD
Association de la Pharmacie des Hôpitaux de l'Est Lémanique
Rennaz
AT
ADC Therapeutics SA
Epalinges
AS
Asceneuron SA
Eysins